The Use of DOACs in Older Individuals Webinar

This session examines the recommendations for use of each class of anticoagulants according to age and comorbidities, the implications for laboratory tests, and clinical implications for the patient. The session also addresses indications and contraindications and which drug and test to use for pediatrics.

At the end of this session, you will be able to:
Explain the indications for anticoagulation
Define DOACs and NOACs and how they work
Explain how DOACs are started in atrial fibrillation 
Explain how DOACs affect coagulation tests
Identify precautions to take when precscribing DOACs
Explain how to deal with bleeding and surgeries for patient under DOAC therapy

Please Note: The information presented here is meant for educational purposes only. It does not represent any treatment or therapy recommendation.

Dr. Jecko Thachil, MD is an honorary consultant in haemostasis and thrombosis at Manchester Royal Infirmary Hospital and clinical academic professor of infection and global health at the University of Manchester, UK. He is a member of the Subcommittee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Hemostasis and is the editor of the journal Physicians' Information and Education Resource for the American College of Physicians. He is the author of more than 70 publications in specialized journals and co-author of the guideline on DIC of the British Committee for Standards in Hematology.